Matthew Vincent Dolan, EVP, Strategy & Corporate Development at DEXCOM INC (DXCM), sold 2,366 shares at $86.91 ($206K) on 2025-01-29, disclosed to the SEC on 2025-01-30.
Open-market sale of $206k DXCM by EVP, Strategy & Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.91 | 1,183 | $103K | 50.0% |
| 2 | $86.91 | 1,183 | $103K | 50.0% |
| Total | $86.91 avg | 2,366 | $206K | 100% |
| Filing → |
| DXCM | SELL | 2024-03-19 | $1.1M | — | Filing → |
| DXCM | SELL | 2024-03-14 | $1.8M | — | Filing → |
| DXCM | SELL | 2023-09-01 | $6K | — | Filing → |